Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 31/5/2020
SIETES contiene 93020 citas

 1 a 20 de 99 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M, Duckworth WC, Hayward RD, VADT Investigators. Intensive glucose control in patients with type 2 diabetes - 15-year follow-up. N Engl J Med 2019;380:6 de junio. [Ref.ID 103135]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
3. Cita con resumen
Young K. Diabetes guidelines updated. Journal Watch 2018:1. [Ref.ID 102893]
4. Cita con resumen
Young LA, Buse JB, Weaver MA, Vu MB, Mitchell M, Blakeney T, Grimm K, Rees J, Niblock F, Donahue KE, for the Monitor Trial Group. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings. A randomized trial. JAMA Intern Med 2017;177:920-9. [Ref.ID 102017]
5. Cita con resumen
Hu Y-m, Zhou F, Yuan Y, Xu Y-c. Efectos del suplemento de probióticos en pacientes con diabetes tipus 2: mataanálisis de ensayos aleatorizados. Med Clin (Barc) 2017;148:362-70. [Ref.ID 101575]
6. Cita con resumen
Anónimo. Google’s life sciences division to work with Sanofi on better ways to manage diabetes. DIA Daily 2015:1 de septiembre. [Ref.ID 99429]
7. Cita con resumen
Jenkins DJA, Kendall CWC, Vuksan V, Faulkner D, Augustin LSA, Mitchell S, Ireland C, Srichaikul K, Mirrahimi A, Chiavaroli L, Mejia SB, Nishi S, Sahye-Pudaruth S, Patel D, Bashyam B, Vidgen E, de Souza RJ, Sievenpiper JL, Coveney J, Josse RG, Leiter LA. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care 2014;37:1806-14. [Ref.ID 97658]
8. Cita con resumen
Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, Budnitz DS. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-86. [Ref.ID 97300]
9.Tiene citas relacionadas
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. The authors reply. N Engl J Med 2013;369:2459. [Ref.ID 96682]
10.Tiene citas relacionadas
Vandecasteele SJ, De Vriese AS. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458-9. [Ref.ID 96681]
11.Tiene citas relacionadas Cita con resumen
Cherney D, Maahs DM. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458. [Ref.ID 96680]
12. Cita con resumen
Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Sequist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA 2013;310:2523-32. [Ref.ID 96673]
13. Cita con resumen
Kuehn BM. FDA warning and study highlight fluoroquinolone risks. JAMA 2013;310:1014. [Ref.ID 96081]
14. Cita con resumen
Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi S, Krumholz HM, Karter AJ. HbA1c and risk of severe hypoglycemia in type 2 diabetes. The Diabetes and Aging Study. Diabetes Care 2013;36:3535-42. [Ref.ID 95844]
15. Cita con resumen
DiPietro L, Gribok A, Stevens MS, Hamm LF, Rumpler W. Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care 2013;36:3262-8. [Ref.ID 95634]
16. Cita con resumen
Yeh H-C, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012;157:336-47. [Ref.ID 93716]
17. Cita con resumen
Anónimo. Criterios de utilización de tiras de determinación de glucemia capilar. Sacylite. Boletín de Informatión Terapéutica 2012:1-5. [Ref.ID 93255]
18. Cita con resumen
Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and association with all-cause and CVD mortality among US adults. JAMA 2012;307:1273-83. [Ref.ID 92567]
19. Cita con resumen
Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ 2012;344:14. [Ref.ID 92516]
20. Cita con resumen
Anónimo. Is routine self-monitoring of blood glucose of benefit in type 2 diabetes?. Drug Ther Bull 2012;50:26. [Ref.ID 92456]
Seleccionar todas
 1 a 20 de 99 siguiente >>